首页> 外文OA文献 >Efficacy and toxicity of capecitabine/oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX) in adjuvant and metastatic treatment of colorectal cancer in patients at the Southern Arizona Veteran Affairs Health Care System

【2h】

Efficacy and toxicity of capecitabine/oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX) in adjuvant and metastatic treatment of colorectal cancer in patients at the Southern Arizona Veteran Affairs Health Care System

机译：卡培他滨/奥沙利铂（XELOX）与5-氟尿嘧啶/亚叶酸/奥沙利铂（FOLFOX）与南亚利桑那州退伍军人事务卫生保健系统对大肠癌的辅助和转移治疗的疗效和毒性

页面导航

摘要
著录项
相似文献
相关主题

摘要

Class of 2017 Abstract

机译：2017年级摘要

著录项

作者
Cushing Merta; Truong Thao;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 en_US
中图分类

相似文献

外文文献
中文文献
专利

1. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. [J] . Ducreux M, Bennouna J, Hebbar M, International Journal of Cancer =: Journal International du Cancer . 2011,第3期

机译：卡培他滨加奥沙利铂（XELOX）与5-氟尿嘧啶/亚叶酸钙加奥沙利铂（FOLFOX-6）作为转移性结直肠癌的一线治疗。
2. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. [J] . Rothenberg ML, Cox JV, Butts C, Annals of oncology: official journal of the European Society for Medical Oncology . 2008,第10期

机译：卡培他滨加奥沙利铂（XELOX）与5-氟尿嘧啶/亚叶酸加奥沙利铂（FOLFOX-4）作为转移性结直肠癌的二线治疗：一项III期非劣效性随机研究。
3. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study [J] . M. L. Rothenberg1 J. V. Cox2 C. Butts3 M. Navarro4 Y.-J. Bang5 R. Goel6 S. Gollins7 L. L. Siu8 S. Laguerre9 and D. Cunningham10 Annals of Oncology . 2008,第10期

机译：卡培他滨加奥沙利铂（XELOX）与5-氟尿嘧啶/亚叶酸加奥沙利铂（FOLFOX-4）作为转移性结直肠癌的二线治疗：一项随机的非III期临床研究
4. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer [O] . Dimitrios Pectasides, Vasilios Karavasilis, George Papaxoinis, 2015

机译：III期临床试验比较卡培他滨与奥沙利铂（CAPOX）组合与5-氟尿嘧啶亚叶酸和奥沙利铂（改良的FOLFOX6）组合作为辅助治疗手术后高危II期或III期结直肠癌患者的临床试验
5. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer [O] . Michel Ducreux, Jaafar Bennouna, Mohamed Hebbar, 2010

机译：Capecitabine Plus Oxaliplatin（Xelox）与5-氟尿嘧啶/ Leucovorin加上oxaliplatin（Folfox-6）作为转移性结直肠癌的一线治疗

Efficacy and toxicity of capecitabine/oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX) in adjuvant and metastatic treatment of colorectal cancer in patients at the Southern Arizona Veteran Affairs Health Care System

摘要

著录项

相似文献

相关主题

期刊订阅